In a historic move, the U.S. National Institutes of Health (NIH) announced today that it will no longer seek research ...

The White House’s plans to make significant cuts to funding from NIH is expected to have significant impact on the pharma industry for years to come. Justin Kozak, an executive VP at Founder Shield, ...

Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory ...

Guidance from the Office of the General Counsel at the Department of Health and Human Services, obtained by STAT, outlines a ...

Opinion Opinion: NIH cuts will slow the science that builds future cancer cures by Anvita Komarla June 21, 2025, 10:00 a.m.

When 16 attorneys general sued the Trump administration over its cancelation of National Institutes of Health research grants ...

NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...

The NIH will no longer accept grant applications that solely use animal testing models, instead requiring applicants to use AI models for human outcomes.

Federal rulings pausing NIH grant cuts highlight an unprecedented, adversarial shift in U.S. research funding, leaving academic medicine institutions wary of deeper rifts. In June, federal judges ...

Proposed cuts to public funding for early science have led to an outcry in scientific circles. For biopharma leaders, the effects are still up in the air.

Below is a state-by-state breakdown of NIH grant funding losses, offering a snapshot of where grant terminations are being felt the most. Massachusetts — $1,274,165,191 New York — $487,367,224 ...

The National Institutes of Health announced major reductions to indirect costs for research funding Feb. 7 in a move many experts say would cause serious harm to lifesaving medical ...